Institutions Hustle To Meet NIH Ethics Training Mandate

Universities and other grant recipients seek to comply with requirement that curricula include moral rectitude courses "So what do you do if you see misconduct in scientific research?" asked a student at last month's introductory lecture for a new "Ethics in Research" series, organized jointly by New York's Rockefeller University, Cornell University Medical College, and the Sloan-Kettering Institute. Cornell medical dean, Robert Michels responded to the question by voicing his school's offici

Written byRobin Eisner
| 12 min read

Register for free to listen to this article
Listen with Speechify
0:00
12:00
Share

Cornell medical dean, Robert Michels responded to the question by voicing his school's official policy. But in his talk he also supplied a few addenda: He reminded the student, for instance, that whistle-blowers don't get treated well by our society, and that it's not generally accepted to rat on your friends.

But he also added the overriding message: The greater moral imperative is to tell the truth--even at the risk of personal disadvantage.

These days, such pronouncements on misconduct, whistle-blowing, moral imperatives, and the like are being heard not only in the lecture halls of the three prestigious New York institutions, but in nearly 150 other universities and research facilities nationwide. Most of these institutions are staging seminars, lecture series, and courses on ethics as their way of meeting a 1989 National Institutes of Health requirement, now being enforced, that postdoctoral fellows and graduate students supported by a particular type ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies